WINNIPEG, MANITOBA -- (Marketwired) -- 09/20/13 -- Miraculins Inc. (TSX VENTURE: MOM), (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, is pleased to announce the ...
↧